Local Factors in the Onset/Progression of Peri-implantitis: A Retrospective Study
1 other identifier
observational
100
1 country
1
Brief Summary
With the increasing burden of peri-implantitis worldwide, interest in the management of this pathology has flourished. However, there is a lack of consensus in the search for a predictable therapy. Different therapeutic modalities have been advocated. Non-surgical therapy as a sole modality is often insufficient to resolve inflammation. Surgical interventions have demonstrated more favorable results. Among these, evidence supported the application of resective, reconstructive or combined approaches to limit progressive bone loss and achieve soft tissue health. However, to date, the most appropriate modality is unknown and the decision-making process derives from the understanding gained in the management of periodontitis. A very relevant aspect of peri-implantitis is that the prevalence tends to be higher at the patient level than at the implant level. This indicates that it is a pathology in which there are localized factors that may contribute to the onset and/or perpetuation of the pathology. Some of the factors that have been demonstrated in the literature point to the characteristics of the peri-implant soft tissues, as well as the position of the dental implants. However, the role of each local factor in the predisposition or protection of peri-implant disease or health is still largely unknown. The objective of this study is therefore to evaluate, in partially edentulous patients with multiple implants, the localized factors associated with peri-implantitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2024
CompletedFirst Submitted
Initial submission to the registry
December 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2026
CompletedJune 8, 2026
December 1, 2024
5 months
December 4, 2024
June 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Peri-implantitis
Bone loss (≥3mm) occurring with clinical signs of inflammation
>12 months
Interventions
Impact of implant-related local factors on the onset/progression of peri-implantitis
Eligibility Criteria
Partially edentulous patients with dental implants exhibiting peri-implantitis
You may qualify if:
- Partially edentulous patients
- Peri-implantitis and non-peri-implantitis implants
- Readable x-ray and clinical signs of inflammation/health
You may not qualify if:
- Complete edentulous patients
- Inconsistent definition of peri-implantitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Implantologia Cirugia Oral y Maxilofacial
Badajoz, 06011, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alberto Monje Correa, DDS, MS, PhD
CICOM MONJE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2024
First Posted
June 8, 2026
Study Start
August 10, 2024
Primary Completion
January 10, 2025
Study Completion
January 10, 2025
Last Updated
June 8, 2026
Record last verified: 2024-12